A birthday gift from Anil Singhvi… will it rain profits? Check out his 2 long-term picks

1 day ago 1

On the special occasion of his birthday, Zee Business Managing Editor Anil Singhvi has gifted investors two high-potential stocks with multibagger potential over the next 1–3 years. Both stocks, Jubilant Pharmova and SG Finserv have strong fundamentals, sector tailwinds, and attractive valuations. Singhvi has shared long-term targets for both counters and recommended a 15 per cent SIP strategy on dips.

Jubilant Pharmova

Jubilant Pharmova is Singhvi’s ‘Pick of the Year’, first recommended on January 1 at Rs 545. The stock currently trades around Rs 1,050 and still offers a solid entry point. The company has a robust presence in the API and generics segment, especially in the US, and its radiopharmaceutical and fill-finish verticals are also performing strongly.

Singhvi highlighted that all five business segments of Jubilant Pharmova are delivering consistent growth, contributing to its long-term wealth creation potential. The company is currently valued at 9x EV/EBITDA on FY26 projections, considered cheap for its sector. Singhvi’s long-term targets are Rs 1,500, Rs 1,700 and Rs 2,000, with a recommendation to buy in phases on corrections.

SG Finserv

SG Finserv is a rising player in the NBFC space, focused on supply chain financing. Singhvi lauded the company’s strong promoter background and low NPA levels, along with its stable credit rating. The business model is seen as highly scalable, and growth visibility remains strong over the next 3 years.

Singhvi believes SG Finserv is well-positioned for a strong re-rating. He has set long-term price targets of Rs 550, Rs 650 and Rs 800 and advised using the SIP route buying in small quantities on every 15 per cent decline.